MiniMed Group, Inc. cash flow to debt ratio of -135.86% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

MiniMed Group, Inc.'s free cash flow has decreased 692.45% from $-53.00M last year to $-420.00M, signaling decreasing performance

MiniMed Group, Inc.'s debt to equity ratio is 0.02, which means that the company's assets are healthy financed, signaling financial stability.

MiniMed Group, Inc.'s debt has increased relative to shareholder equity from 0.00 last year to 0.02 today, signaling weakened financials

MiniMed Group, Inc. has a net cash position, so leverage is healthy.

Interest expense is not separately reported in MiniMed Group, Inc.'s latest filing, so interest coverage cannot be calculated.

MiniMed Group, Inc.'s profit margin was -9.21% last year and is -10.21% this year, signaling decreasing performance

MiniMed Group, Inc.'s short-term assets of $1.35B exceed its short-term liabilities of $702.00M

MiniMed Group, Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization

MiniMed Group, Inc.'s return on equity of -9.11%, is lower than 15.00%, indicating bad performance

MiniMed Group, Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

MiniMed Group, Inc. has insufficient public price history to evaluate earnings stability.

MiniMed Group, Inc. has negative free cash flow, indicating the company is burning cash rather than generating it

MiniMed Group, Inc. has negative free cash flow, indicating cash burn

MiniMed Group, Inc.'s yearly earnings has decreased 32.40% since last year from $-250.00M to $-331.00M, signaling decreasing performance

MiniMed Group, Inc.'s yearly revenue has increased 14.25% since last year from $2.71B to $3.10B, signaling increasing performance

ROIC 0.43% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

MiniMed Group, Inc.'s 3-year revenue CAGR of 11.38% is positive, indicating growing revenue over the past 3 years

MiniMed Group, Inc. has insufficient public price history to evaluate revenue consistency.

MiniMed Group, Inc. has insufficient public price history to evaluate ROE consistency.

MiniMed Group, Inc. has insufficient data to evaluate this check.

MiniMed Group, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

MiniMed Group, Inc. is overvalued relative to its fair value price of 0.00 based on Base EBITDA Valuation model

MiniMed Group, Inc. has an EV/EBITDA ratio of 25.01x, which exceeds the 20.00x threshold, indicating the stock may be overvalued relative to its operating earnings

MiniMed Group, Inc. has insufficient data to evaluate this check.

MiniMed Group, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

MiniMed Group, Inc. has a price-to-book ratio of 1.46x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value

MiniMed Group, Inc. has a price-to-sales ratio of 1.64x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue